ArticleNeuro-oncology advances

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

Hao-Wen Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.